Aug 2026· Statistica sinica· 0 citations· 22 references
Mathematics
TL;DR
A new inference method for conducting multiple-treatment comparisons involving endpoints within the generalized linear model (GLM) framework under covariate-adaptive randomization (CAR) that can effectively control Type I error while potentially improving power.
Abstract
Modern medical research, such as dose-finding studies, seamless trials, and shared control designs, often involves comparing multiple treatments simultaneously. Despite its wide applications, most research focuses on continuous endpoints, leaving the inference for general outcome types in high demand. In this article, we propose a new inference method for conducting multiple-treatment comparisons involving endpoints within the generalized linear model (GLM) framework under covariate-adaptive randomization (CAR). First, we investigate the asymptotic properties of the standard Wald z-statistics (z-scores) in multi-arm trials, highlighting issues when the working model is misspecified, particularly through omitted covariates. Our theoretical findings reveal that these \textcolor{black}{z-scores} do not consistently converge to a standard multivariate normal distribution, leading to either conservative or inflated Type I error rates, depending on the specific GLM endpoint. Second, based on these theoretical results, we develop adjusted test statistics to correct the distributional problems. To appropriately control the family-wise Type I error rate inherent in multi-arm comparisons, we incorporate our adjusted statistics with Simes-type multiple-testing procedures. This robust inference method can effectively control Type I error while potentially improving power. Extensive simulation studies and a real-world application to a metastatic breast cancer trial confirm the effectiveness and practicality of our approach.
The log-rank test and Kaplan--Meier plot are standard tools for analyzing time-to-event data in randomized clinical trials, yet neither provides a summary of the magnitude of the treatment effect. Practitioners typically fill this gap by reporting a hazard ratio from a Cox proportional-hazards model or an acceleration...
Lucy D'Agostino McGowan, Joseph Rigdon, Xin-Ran Li et al.· 0 citations
Marginal Mann-Whitney effects are widely used across various fields of research, and extensions of this estimand have been developed in many directions in statistical methodology. In this paper, we focus on an extensions for repeated measurements and factorial designs subject to randomly missing data. In a previous wor...
Dennis Dobler, Jörg-Tobias Kuhn, L. Amro et al.· 0 citations
A novel jackknife-based approach to covariate adjustment through generalized linear models (GLMs), which is term as JAckknife Score-based Adjustment (JASA), together with its calibrated version JASACal, which can adjust for a much greater number of covariates than existing benchmarks.
Si-Hui Zhao, Xin-Bo Wang, Yong-Yong Ren et al.· 0 citations
The proposed framework provides a flexible and interpretable approach to treatment effect inference under distributional heterogeneity and achieves a favorable balance between robustness and statistical efficiency.
K. Maruo, Ryota Ishii, Yusuke Yamaguchi et al.· 0 citations
The efficient randomized-adaptive design attains the minimal possible variance of the allocation proportion for any pre-specified target and has been extended from two to several treatment arms, but both versions target a single response. Confirmatory trials increasingly rely on several prioritized endpoints, typically...
A formal framework for assessing subgroup treatment effect consistency for time-to-event outcomes within the Cox proportional hazards model is developed and it is proved the asymptotic validity of all procedures and empirically that the new tests are more powerful than their TOST counterparts.
Lukas Koletzko, Holger Dette, B. Bornkamp et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.